bf/NASDAQ:BPMC_icon.jpeg

COM:BLUEPRINTMEDICINES

Blueprint Medicines

  • Stock

Last Close

96.62

22/11 21:00

Market Cap

5.90B

Beta: -

Volume Today

663.53K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-27.03M
-
-27.03M
0%
-217.01M
-
-212.72M
1.98%
15.20M
107.15%
25.76M
69.47%
25.46M
1.15%
average payables
1.11M
-
1.63M
46.72%
2.33M
42.73%
2.98M
27.63%
3.52M
18.25%
4.05M
14.90%
4.58M
13.25%
6.35M
38.63%
5.53M
12.92%
3.72M
32.75%
average receivables
1.71M
-
3.50M
104.77%
1.79M
48.83%
11.71M
-
24.36M
108.10%
31.17M
27.95%
36.98M
18.65%
40.06M
8.31%
book value per share
-0.11
-
2.71
2,468.25%
7.90
191.55%
7.75
1.83%
16.51
113.02%
9.55
42.15%
9.71
1.64%
26.96
177.66%
16.59
38.46%
8.63
47.98%
2.16
75.01%
capex per share
-0.02
-
-0.05
172.37%
-0.27
400.46%
-0.09
68.02%
-0.41
379.35%
-0.29
29.59%
-0.29
1.38%
-0.06
80.23%
-4.46
7,606.72%
-0.15
96.65%
-0.27
77.36%
capex to depreciation
-0.51
-
-1.13
119.39%
-5.15
357.69%
-1.49
71.11%
-9.83
560.63%
-2.99
69.63%
-2.66
10.75%
-0.48
81.92%
-40.32
8,271.85%
-0.76
98.12%
-1.38
81.17%
capex to operating cash flow
0.01
-
0.02
46.38%
0.15
679.58%
0.10
37.70%
0.13
34.76%
0.07
44.03%
0.05
30.42%
-0.01
116.19%
0.87
10,817.05%
0.02
97.97%
0.04
107.06%
capex to revenue
-0.43
-
-0.08
80.21%
-0.72
754.14%
-0.28
60.67%
-0.21
26.01%
-0.00
98.11%
-1.45
36,350.35%
-0.04
96.99%
-0.06
47.34%
cash per share
0.15
-
3.61
2,277.45%
8.92
147.10%
15.65
75.43%
25.04
59.99%
11.26
55.03%
10.11
10.23%
15.99
58.13%
8.15
49.00%
15.84
94.33%
11.73
25.94%
days of inventory on hand
7.37K
-
444.03
93.97%
608.51
37.04%
316.68
47.96%
days payables outstanding
3.75K
-
169.60
95.48%
55.92
67.03%
70.28
25.68%
days sales outstanding
109.31
-
47.01
56.99%
128.48
-
11.64
90.94%
75.06
544.89%
66.08
11.96%
63.20
4.36%
debt to assets
0.69
-
0.18
73.84%
0.04
75.95%
0.02
47.24%
0.03
18.93%
0.03
10.62%
0.14
348.41%
0.05
61.54%
0.09
70.62%
0.18
101.88%
0.66
267.40%
debt to equity
-1.91
-
0.26
113.34%
0.05
78.79%
0.03
43.64%
0.03
2.79%
0.04
24.31%
0.21
430.15%
0.06
70.50%
0.11
88.29%
0.47
310.46%
5.30
1,025.32%
dividend yield
0.00
-
0.00
123.18%
0.00
53.69%
earnings yield
-0.08
-
-0.16
92.64%
-0.11
32.68%
-0.09
14.43%
-0.05
44.72%
-0.10
92.54%
-0.09
14.27%
0.05
159.82%
-0.10
300.23%
-0.21
107.64%
-0.09
57.46%
enterprise value
247.75M
-
208.68M
15.77%
321.58M
54.10%
506.30M
57.44%
2.19B
333.13%
2.31B
5.40%
3.81B
64.99%
5.52B
44.77%
6.17B
11.74%
2.74B
55.66%
6.29B
129.88%
enterprise value over ebitda
-12.22
-
-5.32
56.45%
-6.18
16.04%
-7.03
13.83%
-14.83
110.93%
-9.77
34.10%
-10.55
8.02%
17.88
269.45%
-9.61
153.73%
-5.09
47.04%
-13.25
160.35%
ev to operating cash flow
-13.02
-
-5.89
54.73%
-10.15
72.22%
-20.65
103.45%
-18.30
11.42%
-13.21
27.81%
-13.72
3.86%
14.26
203.99%
-20.66
244.81%
-5.45
73.63%
-14.40
164.31%
ev to sales
28.21
-
18.23
35.37%
102.35
461.41%
51.92
49.27%
57.34
10.44%
6.96
87.87%
34.26
392.53%
13.41
60.86%
25.22
88.08%
free cash flow per share
-1.47
-
-2.76
87.22%
-2.00
27.35%
-0.98
51.25%
-3.58
266.54%
-4.28
19.44%
-6.11
42.71%
7.04
215.29%
-9.57
235.92%
-8.57
10.42%
-7.48
12.74%
free cash flow yield
-0.08
-
-0.15
87.22%
-0.08
47.95%
-0.03
54.22%
-0.05
36.34%
-0.08
67.08%
-0.08
3.97%
0.06
182.35%
-0.09
242.32%
-0.20
119.02%
-0.08
58.56%
graham net net
-0.28
-
2.50
998.57%
7.15
185.60%
12.23
71.11%
22.61
84.89%
8.50
62.41%
0.85
89.97%
11.86
1,291.54%
4.00
66.24%
2.55
36.22%
-2.72
206.69%
graham number
2.03
-
13.70
575.44%
22.67
65.53%
21.44
5.42%
38.16
77.93%
34.05
10.76%
38.75
13.79%
59.09
52.49%
64.09
8.48%
42.60
33.53%
20.16
52.69%
income quality
0.91
-
0.88
3.41%
0.60
31.69%
0.34
43.67%
0.81
139.33%
0.74
8.61%
0.80
8.12%
1.23
54.21%
0.46
62.40%
0.90
94.29%
0.86
4.36%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-152.17
-
-87.71
42.36%
-74.20
15.40%
-154.75
108.55%
-684.38
342.25%
-3.38K
394.46%
-26.70
99.21%
-32.76
-
-9.42
71.23%
interest debt per share
0.23
-
0.73
216.39%
0.47
35.87%
0.25
45.55%
0.52
106.54%
0.37
28.57%
2.29
513.24%
1.64
28.35%
1.90
15.87%
4.35
128.29%
12.29
182.67%
inventory turnover
0.05
-
0.82
1,559.71%
0.60
27.03%
1.15
92.15%
invested capital
-1.91
-
0.26
113.34%
0.05
78.79%
0.03
43.64%
0.03
2.79%
0.04
24.31%
0.21
430.15%
0.06
70.50%
0.11
88.29%
0.47
310.46%
5.30
1,025.32%
market cap
246.88M
-
246.88M
0%
480.34M
94.57%
771.15M
60.54%
2.85B
269.57%
2.36B
17.02%
3.83B
62.02%
6.12B
59.62%
6.27B
2.48%
2.61B
58.31%
5.59B
113.78%
net current asset value
-3.18M
-
33.78M
1,161.20%
135.50M
301.14%
150.71M
11.23%
593.74M
293.97%
378.67M
36.22%
273.45M
27.79%
679.45M
148.47%
272.54M
59.89%
211.43M
22.42%
-110.25M
152.14%
net debt to ebitda
-0.04
-
0.97
2,354.54%
3.05
212.96%
3.68
20.61%
4.44
20.81%
0.23
94.91%
0.05
77.96%
-1.93
3,971.56%
0.15
107.96%
-0.23
248.77%
-1.48
548.51%
net income per share
-1.60
-
-3.08
92.64%
-2.89
6.02%
-2.64
8.87%
-3.92
48.63%
-5.39
37.64%
-6.87
27.40%
5.76
183.75%
-11.01
291.23%
-9.35
15.07%
-8.37
10.44%
operating cash flow per share
-1.45
-
-2.71
86.07%
-1.74
35.80%
-0.89
48.67%
-3.17
255.71%
-3.99
25.79%
-5.81
45.70%
7.10
222.10%
-5.10
171.91%
-8.42
65.01%
-7.21
14.34%
payables turnover
0.10
-
2.15
2,112.93%
6.53
203.29%
5.19
20.44%
receivables turnover
3.34
-
7.76
132.51%
2.84
-
31.36
1,003.92%
4.86
84.49%
5.52
13.59%
5.78
4.56%
research and ddevelopement to revenue
4.26
-
2.92
31.46%
6.75
131.16%
5.47
18.97%
4.98
8.93%
0.41
91.74%
3.34
710.49%
2.34
29.89%
1.67
28.70%
return on tangible assets
-5.06
-
-0.81
84.04%
-0.29
63.44%
-0.26
13.09%
-0.21
19.27%
-0.44
111.71%
-0.46
6.01%
0.18
139.33%
-0.51
381.59%
-0.41
19.70%
-0.48
16.99%
revenue per share
0.63
-
1.01
61.59%
0.57
43.88%
1.01
79.02%
1.39
37.02%
14.55
946.65%
3.08
78.86%
3.42
11.17%
4.12
20.37%
roe
13.98
-
-1.14
108.13%
-0.37
67.77%
-0.34
7.17%
-0.24
30.23%
-0.56
137.91%
-0.71
25.34%
0.21
130.16%
-0.66
410.76%
-1.08
63.26%
-3.88
258.34%
roic
-15.63
-
-0.90
94.23%
-0.33
63.68%
-0.32
1.33%
-0.23
28.09%
-0.57
146.79%
-0.53
7.88%
0.18
134.57%
-0.55
398.96%
-0.64
18.05%
-0.54
16.43%
sales general and administrative to revenue
1.27
-
0.69
45.43%
1.31
88.76%
1.08
17.58%
1.45
34.62%
shareholders equity per share
-0.11
-
2.71
2,468.25%
7.90
191.55%
7.75
1.83%
16.51
113.02%
9.55
42.15%
9.71
1.64%
26.96
177.66%
16.59
38.46%
8.63
47.98%
2.16
75.01%
stock based compensation to revenue
0.45
-
0.22
51.34%
0.58
164.37%
0.69
17.34%
0.82
19.81%
0.10
88.42%
0.51
434.75%
0.49
4.67%
0.37
23.39%
tangible asset value
-1.50M
-
35.43M
2,468.25%
143.98M
306.39%
213.08M
47.99%
623.97M
192.84%
419.01M
32.85%
464.36M
10.82%
1.47B
216.58%
970.74M
33.97%
514.68M
46.98%
130.61M
74.62%
tangible book value per share
-0.11
-
2.71
2,468.25%
7.90
191.55%
7.75
1.83%
16.51
113.02%
9.55
42.15%
9.71
1.64%
26.96
177.66%
16.59
38.46%
8.63
47.98%
2.16
75.01%
working capital
-705K
-
41.51M
5,987.94%
151.78M
265.64%
191.91M
26.44%
642.62M
234.85%
439.46M
31.61%
410.30M
6.64%
796.96M
94.24%
404.26M
49.27%
863.42M
113.58%
593.47M
31.26%

All numbers in (except ratios and percentages)